Kawaoka T - Search Results

1

Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes.

Kondo H, Hazama S, Kawaoka T, Yoshino S, Yoshida S, Tokuno K, Takashima M, Ueno T, Hinoda Y, Oka M. Kondo H, et al. Among authors: kawaoka t. Anticancer Res. 2008 Jan-Feb;28(1B):379-87. Anticancer Res. 2008. PMID: 18383873 Free article. Clinical Trial.

2

[Clinical evaluation of intrapleural or peritoneal administration of lentinan and OK-432 for malignant effusion].

Kawaoka T, Yoshino S, Hazama S, Tangoku A, Oka M. Kawaoka T, et al. Gan To Kagaku Ryoho. 2003 Oct;30(11):1562-5. Gan To Kagaku Ryoho. 2003. PMID: 14619464 Japanese.

3

Immunological evaluation of personalized peptide vaccination for patients with pancreatic cancer.

Yamamoto K, Mine T, Katagiri K, Suzuki N, Kawaoka T, Ueno T, Matsueda S, Yamada A, Itoh K, Yamana H, Oka M. Yamamoto K, et al. Among authors: kawaoka t. Oncol Rep. 2005 May;13(5):874-83. Oncol Rep. 2005. PMID: 15809753 Clinical Trial.

4

MUC1 peptide vaccination in patients with advanced pancreas or biliary tract cancer.

Yamamoto K, Ueno T, Kawaoka T, Hazama S, Fukui M, Suehiro Y, Hamanaka Y, Ikematsu Y, Imai K, Oka M, Hinoda Y. Yamamoto K, et al. Among authors: kawaoka t. Anticancer Res. 2005 Sep-Oct;25(5):3575-9. Anticancer Res. 2005. PMID: 16101182 Free article. Clinical Trial.

5

Current antibiotic prophylaxis in pancreatoduodenectomy in Japan.

Ueno T, Yamamoto K, Kawaoka T, Takashima M, Oka M. Ueno T, et al. Among authors: kawaoka t. J Hepatobiliary Pancreat Surg. 2005;12(4):304-9. doi: 10.1007/s00534-005-0975-2. J Hepatobiliary Pancreat Surg. 2005. PMID: 16133697

6

[Clinical evaluation of intrapleural or peritoneal repetitive administration of Lentinan and OK-432 for malignant effusion].

Kawaoka T, Yoshino S, Kondo H, Yamamoto K, Hazama S, Oka M. Kawaoka T, et al. Gan To Kagaku Ryoho. 2005 Oct;32(11):1565-7. Gan To Kagaku Ryoho. 2005. PMID: 16315870 Japanese.

7

[Adoptive immunotherapy using MUC1--specific CTLs for unresectable pancreatic cancer].

Kawaoka T, Takashima M, Yamamoto K, Ueno T, Oka M. Kawaoka T, et al. Nihon Rinsho. 2006 Jan;64 Suppl 1:279-82. Nihon Rinsho. 2006. PMID: 16457266 Review. Japanese. No abstract available.

8

Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.

Kawaoka T, Oka M, Takashima M, Ueno T, Yamamoto K, Yahara N, Yoshino S, Hazama S. Kawaoka T, et al. Oncol Rep. 2008 Jul;20(1):155-63. Oncol Rep. 2008. PMID: 18575732

9

Combination phase II study of weekly paclitaxel and 5'-DFUR for unresectable or recurrent gastric cancer.

Yoshino S, Furuya T, Shimizu R, Ozasa H, Nishimura T, Fukuda S, Kawaoka T, Hazama S, Oka M. Yoshino S, et al. Among authors: kawaoka t. Anticancer Res. 2013 Jun;33(6):2629-33. Anticancer Res. 2013. PMID: 23749919 Clinical Trial.

10

[Five Cases of Ten-Year Survival after Surgical Treatment of Pancreatic Cancer in Yamaguchi Prefecture].

Fujiwara Y, Matsui H, Tokumitsu Y, Shindo Y, Suto R, Kato T, Kawaoka T, Ueno T, Tanabe M, Harada E, Kaino S, Ito K, Hamano K, Sakaida I, Nagano H. Fujiwara Y, et al. Among authors: kawaoka t. Gan To Kagaku Ryoho. 2019 Dec;46(13):2431-2433. Gan To Kagaku Ryoho. 2019. PMID: 32156955 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters